BactiVac: Catalyst Pump-Priming Projects

  30 March 2022

Catalyst funding for pump-priming projects is available to support collaborations between Network members in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and industry, and acquire the data to support substantive funding applications.

The catalyst funds are flexible, typically up to £50,000 and expect to provide deliverables within 6 months post-award. This catalyst funding scheme prioritise projects that:

  • Facilitate onward progression of bacterial vaccines along the pipeline to licensure
  • Offer robust solutions to overcome the difficult preclinical to clinical transition
  • Advance the ability to tackle the global challenge of antimicrobial resistance (AMR)
  • Involve BactiVac partnerships, particularly new partnerships, with a long-term work plan
  • Include LMICs and/or industrial partners
  • Demonstrate a clear pathway to impact
  • Have realistic plans in place to demonstrate intellectual property (IP) has been considered
  • Include plans for achieving further substantive funding at the end of the project
Further reading: BactiVac
Author(s): BactiVac
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!